- OpenEvidence
OpenEvidence is FREE for verified U S HCPs Investors include Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Blackstone, Mayo Clinic, and others Don′t miss our weekly email alert Stay up to date on all the new findings that matter © OpenEvidence 2025 All rights reserved
- OpenEvidence - Wikipedia
OpenEvidence is an American artificial intelligence company that develops a medical search engine used by physicians for clinical decision support The company was founded in 2022 by entrepreneur Daniel Nadler and is headquartered in Miami, Florida
- OpenEvidence: The Leading AI App for Doctors - gv. com
OpenEvidence is an AI-powered application that allows physicians to ask natural language questions and get immediate answers grounded in peer-reviewed medical evidence from sources like the New England Journal of Medicine and JAMA
- OpenEvidence raises $210M, unveils AI agents built for advanced medical . . .
OpenEvidence developed an AI-powered medical search engine and generative AI chatbot exclusively for doctors that summarizes and simplifies evidence-based medical information
- OpenEvidence, the Fastest-Growing Application for Physicians in History . . .
OpenEvidence is the fastest-growing clinical decision support platform in the United States, and the most widely used medical search engine among U S clinicians
- OpenEvidence: How AI is Transforming Clinical Research
"OpenEvidence is not just building a company, they're setting a new global standard for how evidence-based medical decisions are made "
- OpenEvidence Safety and Comparative Efficacy of Four LLMs in Clinical . . .
OpenEvidence is an online tool designed to aggregate and synthesize data from peer-reviewed clinical studies, subsequently generating responses to user inquiries through the application of generative AI
- OpenEvidence - bond. libguides. com
OpenEvidence is a medical information platform designed to aggregate, synthesise and visualise clinically relevant evidence Launched from the Mayo Clinic Platform Accelerate program, it features multimedia and clinical findings from The New England Journal of Medicine
|